Market Leadership Cenduit is recognized as the leading IRT systems specialist globally, with extensive clinical trial expertise across over 100 countries and interactions with more than 600,000 patients, positioning it as a key player for biopharma companies seeking reliable trial technology partnerships.

Innovative Platform The company launched its advanced Cenduit IRT platform and new drug management modules, indicating ongoing commitment to technological innovation, which can appeal to organizations looking to upgrade or expand their trial management capabilities.

Growth & Recognition With recent appointments such as a Senior Director of Project Management and inclusion on the Grant Thornton North Carolina 100® list, Cenduit demonstrates strong growth momentum and industry recognition, making it an attractive partner for expanding clinical operations.

Global Reach Operating with over 500 experts across multiple continents and supporting trials in diverse geographic locations, Cenduit offers extensive global coverage and local insights, which can be advantageous for multinational sponsors seeking comprehensive clinical trial solutions.

Financial Stability Generating between $50 million and $100 million in revenue, Cenduit shows solid financial performance and market presence, providing confidence in its capacity to invest in new services or partnerships within the highly regulated and competitive clinical trial industry.